Search - tctmd.com

Displaying 721 - 740 of 831

Sort: Relevancy | Date

News Daily News

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

May 14, 2014

News Daily News

PLATO Substudy: Ticagrelor Reduces Mortality in NSTE-ACS Patients Regardless of Revascularization

L.A. McKeown

April 25, 2014

News Daily News

HORIZONS-AMI Substudy Examines Effects of Obesity on STEMI Outcomes

Yael L. Maxwell

April 24, 2014

News Daily News

British Registry: Prehospital ECG Associated with Reduced Mortality in ACS Patients

L.A. McKeown

April 18, 2014

News Daily News

Patients with Cardiac Arrest Fare Poorly After PCI

April 17, 2014

News Daily News

PLATO Analysis: No Sex-Based Difference in Ticagrelor’s Safety and Efficacy

April 16, 2014

News Daily News

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

L.A. McKeown

April 11, 2014

News Daily News

High Prasugrel Loading Dose Limits Platelet Reactivity after Primary PCI for STEMI

Caitlin E. Cox

April 09, 2014

News Conference News ACC 2014

HEAT PPCI: Results Favoring Heparin over Bivalirudin Raise Scientific, Ethical Issues

Jason Kahn

March 31, 2014

News Daily News

La Prueba de la Troponina T de Alta Sensibilidad revela una Sólida Capacidad Pronóstica en pacientes STEMI

L.A. McKeown

March 20, 2014

News Daily News

HORIZONS-AMI: Kidney Damage During Primary PCI Closely Tied to Prognosis

March 20, 2014

News Daily News

High Sensitivity Troponin T Assay Shows Strong Prognostic Ability in STEMI Patients

L.A. McKeown

March 20, 2014

News Daily News

Statins More Beneficial Before PCI Than After in ACS Patients

March 13, 2014

News Daily News

CHILL-MI Published: Results Show Some Benefit to Cooling in Primary PCI

Caitlin E. Cox

February 06, 2014

News Daily News

Ticagrelor Loading Dose May be Unnecessary for ACS Patients Previously on Clopidogrel

Caitlin E. Cox

January 29, 2014

News Daily News

Meta-analysis: Good Bleeding Profile with Dabigatran vs. Warfarin for A-fib, VTE

L.A. McKeown

January 27, 2014

News Daily News

Transradial Approach May Balance Bleeding Benefits of Bivalirudin in Primary PCI

Jason Kahn

January 15, 2014

News Daily News

Studies Explore How, When Radial PCI Benefits ACS/STEMI Patients

January 01, 2014

News Daily News

INFUSE-AMI: Thirty-Day Reduction in Infarct Size May Translate to 1-Year Benefit

Caitlin E. Cox

October 11, 2013

News Daily News

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

Caitlin E. Cox

October 11, 2013

Advertisement

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

PLATO Substudy: Ticagrelor Reduces Mortality in NSTE-ACS Patients Regardless of Revascularization

HORIZONS-AMI Substudy Examines Effects of Obesity on STEMI Outcomes

British Registry: Prehospital ECG Associated with Reduced Mortality in ACS Patients

Patients with Cardiac Arrest Fare Poorly After PCI

PLATO Analysis: No Sex-Based Difference in Ticagrelor’s Safety and Efficacy

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

High Prasugrel Loading Dose Limits Platelet Reactivity after Primary PCI for STEMI

HEAT PPCI: Results Favoring Heparin over Bivalirudin Raise Scientific, Ethical Issues

La Prueba de la Troponina T de Alta Sensibilidad revela una Sólida Capacidad Pronóstica en pacientes STEMI

HORIZONS-AMI: Kidney Damage During Primary PCI Closely Tied to Prognosis

High Sensitivity Troponin T Assay Shows Strong Prognostic Ability in STEMI Patients

Statins More Beneficial Before PCI Than After in ACS Patients

CHILL-MI Published: Results Show Some Benefit to Cooling in Primary PCI

Ticagrelor Loading Dose May be Unnecessary for ACS Patients Previously on Clopidogrel

Meta-analysis: Good Bleeding Profile with Dabigatran vs. Warfarin for A-fib, VTE

Transradial Approach May Balance Bleeding Benefits of Bivalirudin in Primary PCI

Studies Explore How, When Radial PCI Benefits ACS/STEMI Patients

INFUSE-AMI: Thirty-Day Reduction in Infarct Size May Translate to 1-Year Benefit

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content